These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1685310)

  • 21. Decreased expression of C3b receptor (CR1) on erythrocytes of patients with systemic lupus erythematosus contrasts with its normal expression in other systemic diseases and does not correlate with the occurrence or severity of SLE nephritis.
    Jouvin MH; Wilson JG; Bourgeois P; Fearon DT; Kazatchkine MD
    Complement; 1986; 3(2):88-96. PubMed ID: 2945697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of multiple restriction fragment length polymorphisms of the gene for the human complement receptor type I. Duplication of genomic sequences occurs in association with a high molecular mass receptor allotype.
    Wong WW; Kennedy CA; Bonaccio ET; Wilson JG; Klickstein LB; Weis JH; Fearon DT
    J Exp Med; 1986 Nov; 164(5):1531-46. PubMed ID: 2877046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
    J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythrocyte complement receptor type 1 in patients with systemic lupus erythematosus.
    Yen JH; Liu HW; Lin SF; Chen JR; Chen TP
    J Rheumatol; 1989 Oct; 16(10):1320-5. PubMed ID: 2810256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Erythrocyte CR1 receptor reactivity in patients with systemic lupus erythematosus].
    Said PB; Sarano J; Manni JA; Casellas AM
    Medicina (B Aires); 1990; 50(1):21-4. PubMed ID: 2149869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C3b receptor (CR1) expression on the polymorphonuclear leukocytes from patients with systemic lupus erythematosus.
    Fyfe A; Holme ER; Zoma A; Whaley K
    Clin Exp Immunol; 1987 Feb; 67(2):300-8. PubMed ID: 2955969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired loss of erythrocyte complement receptor type 1 in patients with diabetic nephropathy undergoing hemodialysis.
    Wakabayashi M; Ohi H; Tamano M; Onda K; Fujita T; Tomino Y
    Nephron Exp Nephrol; 2006; 104(3):e89-95. PubMed ID: 16837818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-C3b-receptor (CR1) antibodies in patients with systemic lupus erythematosus.
    Cook JM; Kazatchkine MD; Bourgeois P; Mignon F; Mery JP; Kahn MF
    Clin Immunol Immunopathol; 1986 Jan; 38(1):135-8. PubMed ID: 2934195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited.
    Walport MJ; Ross GD; Mackworth-Young C; Watson JV; Hogg N; Lachmann PJ
    Clin Exp Immunol; 1985 Mar; 59(3):547-54. PubMed ID: 3987091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C3b receptor (CR1) on phagocytic cells from SLE patients: analysis of the defect and familial study.
    Mir A; Porteu F; Levy M; Lesavre P; Halbwachs-Mecarelli L
    Clin Exp Immunol; 1988 Sep; 73(3):461-6. PubMed ID: 2974768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A rare complement component C4 restriction fragment length polymorphism in two families with systemic lupus erythematosus.
    Goldstein R; Moulds JM; Sengar DP
    J Rheumatol; 1991 Mar; 18(3):345-8. PubMed ID: 1677422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Association between genetic polymorphism of erythrocyte CR1 and the susceptibility of idiopathic pulmonary fibrosis].
    Yuan YD; Zhao MX; Yu J
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Nov; 34(11):841-5. PubMed ID: 22333472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral catabolism of CR1 (the C3b receptor, CD35) on erythrocytes from healthy individuals and patients with systemic lupus erythematosus (SLE).
    Cohen JH; Lutz HU; Pennaforte JL; Bouchard A; Kazatchkine MD
    Clin Exp Immunol; 1992 Mar; 87(3):422-8. PubMed ID: 1531948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
    Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
    J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Size polymorphism of the erythrocyte complement receptor type 1 (CR1) in systemic lupus erythematosus induced by hydralazine.
    Mitchell JA; Sim E
    Complement Inflamm; 1989; 6(2):88-93. PubMed ID: 2721176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis.
    Nath SK; Harley JB; Lee YH
    Hum Genet; 2005 Nov; 118(2):225-34. PubMed ID: 16133175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Normal C3b receptor (CR1) genomic polymorphism in patients with insulin-dependent diabetes mellitus (IDDM): is the low erythrocyte CR1 expression an acquired phenomenon?
    Ruuska PE; Ikäheimo I; Silvennoinen-Kassinen S; Käär ML; Tiilikainen A
    Clin Exp Immunol; 1992 Jul; 89(1):18-21. PubMed ID: 1352745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The change in C3b receptors on erythrocytes from patients with systemic lupus erythematosus.
    Yoshida K; Yukiyama Y; Hirose S; Miyamoto T
    Clin Exp Immunol; 1985 Jun; 60(3):613-21. PubMed ID: 3160514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C3b receptor (CR1) genomic polymorphism in rheumatoid arthritis. Low receptor levels on erythrocytes are an acquired phenomenon.
    Kumar A; Malaviya AN; Sinha S; Khandekar PS; Banerjee K; Srivastava LM
    Immunol Res; 1994; 13(1):61-71. PubMed ID: 7897264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Small increase of CR1 and CR3 by C5a-receptors on polymorphonuclear leukocytes in systemic lupus erythematosus].
    Doi T; Takemura S; Onodera H; Ueda M; Deguchi M; Nakahara R; Ichio N; Nakanishi S; Seto N; Yanagida K; Kondo M
    Arerugi; 1997 Nov; 46(11):1108-13. PubMed ID: 9436327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.